Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) CFO Richard Goldstein was featured in an interview on Midas Letter. In the interview, Goldstein talked about the second round of cannabis legalization by Health Canada and the company’s five-year hemp supply agreement with FSD Pharma Inc, (CSE:HUGE) and World Class Extractions (WCE).

Canntab is a Canadian oral dosage formulation company engaged in the research and development of advanced pharmaceutical-grade formulations of cannabinoids. Canntab has developed a line of immediate-release, modified-release and extended-release oral dose products to be sold in Canada. Currently, Health Canada has permitted the sale of cannabis-based softgel, capsules and flower. However, Health Canada has not approved the sale of cannabis-based pills and edibles, among others, but is expected to do so on or before October 17, 2019. Goldstein believes that Health Canada will legalize edibles and other cannabis products before that date.


Canntab is also looking at expanding into the US, but its focus is on the large cannabis market in Mexico. The company has already established a distribution network in Mexico and will be exporting all of its products internationally from Canada, pending approval from Health Canada.

“Mexico is a great marketplace … There’s a large medical-user base in Mexico. It’s our understanding that, upon Health Canada approval, we should be able to distribute in Mexico,” said Goldstein.

Goldstein also touched on Canntab’s recent supply agreement. Last week, Canntab entered into a three-way, five-year hemp agreement with FSD Pharma and WCE for 1,000 kilograms of organic hemp to extract CBD oil, which will then be processed into gel capsules and tablets at FSD Pharma’s facility in Cobourg, Ontario.

To view the full video, click here.

Click here to connect with Canntab Therapeutics (CSE:PILL, OTC:CTABF, FSE:TBF1) for an Investor Presentation. 

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE:ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws

Keep reading... Show less

TerrAscend Corp. (“TerrAscend” or the “Company”) (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced Jason Ackerman Chief Executive Officer and Executive Chairman of TerrAscend, Keith Stauffer Chief Financial Officer, and Jason Wild Chairman, will participate in three upcoming conferences:

  • Cowen’s 3rd Annual Boston Cannabis Conference, a virtual event taking place November 30-December 2 , 2020. Jason Ackerman will participate in a panel, U.S. MSOs: The West, on November 30, 2020 at 10:25 a.m. ET . Management will also host one-on-one meetings with investors throughout the conference.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit, a virtual event taking place on December 15-16, 2020 . Jason Ackerman is scheduled to participate in a fireside chat on December 16 th at 1:00 p.m. ET . To register for the fireside chat: Click Here
  • 23 rd Annual Needham Virtual Growth Conference, a virtual event taking place January 11-15, 2021 . Jason Ackerman is scheduled to participate in a fireside chat on January 14, 2021 at 2:45 p.m. ET . Management will also host one-on-one meetings with investors throughout the conference. To register for the fireside chat: Click Here

The Canadian Securities Exchange (“CSE”) has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Keep reading... Show less
  • Aurora strategically positioned within two of the largest legal cannabis markets outside of Canada
  • Agreement with Israeli leader Cantek provides access to Israel’s drugstore channel
  • Finished product is co-branded under Aurora and Cantek brands

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today it has entered into a strategic Supply Agreement (the “Agreement”) with Cantek Holdings (“Cantek”), one of Israel’s leaders in the medical cannabis field.

Keep reading... Show less